Argent BioPharma Limited (ASX:RGT)

Argent BioPharma Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	7	14	17	44	85	32
Market Cap Growth	-46.77%	-18.92%	-61.62%	-48.94%	171.31%	-50.06%
Enterprise Value	15	16	25	40	86	32
Last Close Price	0.09	0.30	5.00	16.00	37.00	20.00
PS Ratio	22.94	15.24	4.95	9.23	28.54	15.16
PB Ratio	-0.62	-2.33	-2.09	8.43	6.18	10.18
P/TBV Ratio	-	-	-	16.22	12.60	10.15
EV/Sales Ratio	52.12	18.03	7.38	8.38	28.72	15.56
Debt / Equity Ratio	-0.86	-1.67	-1.21	0.84	0.44	0.61
Asset Turnover	0.03	0.09	0.24	0.22	0.19	0.20
Inventory Turnover	0.86	1.07	1.27	3.08	2.98	7.04
Quick Ratio	0.08	0.10	0.06	0.50	1.27	0.79
Current Ratio	0.16	0.23	0.19	0.84	1.55	1.09
Return on Equity (ROE)	-	-	-	-218.54%	-187.61%	-270.21%
Return on Assets (ROA)	-121.60%	-108.58%	-66.60%	-45.27%	-46.40%	-67.42%
Return on Capital (ROIC)	-282.13%	-401.12%	-168.89%	-65.95%	-60.09%	-89.33%
Earnings Yield	-333.31%	-129.05%	-124.29%	-46.61%	-18.56%	-61.45%
FCF Yield	-164.43%	-108.97%	-72.67%	-34.02%	-17.91%	-34.65%
Buyback Yield / Dilution	-284.88%	-1155.86%	-14.85%	-34.63%	-37.91%	-14.31%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.